Mi, X.; Lou, Y.; Wang, Y.; Dong, M.; Xue, H.; Li, S.; Lu, J.; Chen, X.
Glycyrrhetinic Acid Receptor-Mediated Zeolitic Imidazolate Framework-8 Loaded Doxorubicin as a Nanotherapeutic System for Liver Cancer Treatment. Molecules 2023, 28, 8131.
https://doi.org/10.3390/molecules28248131
AMA Style
Mi X, Lou Y, Wang Y, Dong M, Xue H, Li S, Lu J, Chen X.
Glycyrrhetinic Acid Receptor-Mediated Zeolitic Imidazolate Framework-8 Loaded Doxorubicin as a Nanotherapeutic System for Liver Cancer Treatment. Molecules. 2023; 28(24):8131.
https://doi.org/10.3390/molecules28248131
Chicago/Turabian Style
Mi, Xiao, Yang Lou, Yutian Wang, Mingran Dong, Hongwei Xue, Shuyang Li, Juan Lu, and Xi Chen.
2023. "Glycyrrhetinic Acid Receptor-Mediated Zeolitic Imidazolate Framework-8 Loaded Doxorubicin as a Nanotherapeutic System for Liver Cancer Treatment" Molecules 28, no. 24: 8131.
https://doi.org/10.3390/molecules28248131
APA Style
Mi, X., Lou, Y., Wang, Y., Dong, M., Xue, H., Li, S., Lu, J., & Chen, X.
(2023). Glycyrrhetinic Acid Receptor-Mediated Zeolitic Imidazolate Framework-8 Loaded Doxorubicin as a Nanotherapeutic System for Liver Cancer Treatment. Molecules, 28(24), 8131.
https://doi.org/10.3390/molecules28248131